Prognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysis.

about

Prognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q35858346

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Prognostic value of interim (1 ...... atic review and meta-analysis.

@ast

Prognostic value of interim (1 ...... atic review and meta-analysis.

@en

type

Item

label

Prognostic value of interim (1 ...... atic review and meta-analysis.

@ast

Prognostic value of interim (1 ...... atic review and meta-analysis.

@en

prefLabel

Prognostic value of interim (1 ...... atic review and meta-analysis.

@ast

Prognostic value of interim (1 ...... atic review and meta-analysis.

@en

P1476

Prognostic value of interim (1 ...... atic review and meta-analysis.

@en

P2093

Chang-Ping Wu

http://www.w3.org/2001/XMLSchema#string

Cheng Fang

http://www.w3.org/2001/XMLSchema#string

Danxia Zhu

http://www.w3.org/2001/XMLSchema#string

Jing-Ting Jiang

http://www.w3.org/2001/XMLSchema#string

Jun Wu

http://www.w3.org/2001/XMLSchema#string

Mei Ji

http://www.w3.org/2001/XMLSchema#string

Xiao-Li Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation.

Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study.

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.

Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.

Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy.

P304

15340-15350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26629023

http://www.w3.org/2001/XMLSchema#string

P932

4658912

http://www.w3.org/2001/XMLSchema#string